Door closes on drug discovery. IBM is tapering off sales of its Watson for Drug Discovery product in favor of other healthcare offerings using the AI technology, STAT reported this morning. The ...
As the AI hype-cycle has built, we've been treated to a plethora of claims about what sorts of improvements and breakthroughs the technology can deliver. One of the most fundamental -- and potentially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results